Cicletanine-Induced Decreases in Cytosolic Ca2+ Level and Contraction in Vascular Smooth Muscle.
-
- Izumi Masanori
- Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
-
- Mitsui-Saito Minori
- Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
-
- Ozaki Hiroshi
- Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
-
- Karaki Hideaki
- Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo
書誌事項
- タイトル別名
-
- Cicletanine-Induced Decreases in Cytoso
この論文をさがす
抄録
The mechanism by which cicletanine (3-(4-chlorophenyl)-1, 3-dihydro-7-hydroxy-6-methylfuro-[3, 4-c]pyridine) induces vasodilatation was examined in isolated vascular smooth muscle. Cicletanine inhibited the contraction induced by high K+, norepinephrine (NE) and prostaglandin F2α in a concentration-dependent manner in rat aorta. High K+ (15.8 – 72.7 mM) elicited elevation of cytosolic Ca2+ level ([Ca2+]i) and contraction in a concentration-dependent manner. Cicletanine (300 μM) inhibited the high K+-induced contractions without changing the [Ca2+]i/tension relationship. NE (3 – 300 nM) elicited greater contractions than high K+ at a given [Ca2+]i, suggesting that NE increased Ca2+ sensitivity of the contractile elements. Cicletanine inhibited the NE-induced contractions without changing the slope of the [Ca2+]i/tension relationship. Cicletanine inhibited the transient increases in both [Ca2+]i and muscle tension elicited by NE but not the transient increase in [Ca2+]i elicited by caffeine in Ca2+-free solution. Cicletanine did not inhibit contraction induced by Ca2+ in the permeabilized rabbit mesenteric artery with α-toxin. These results suggest that cicletanine inhibits vascular smooth muscle contraction by multiple mechanisms: 1) inhibition of Ca2+ influx via voltage-dependent Ca2+ channel and 2) inhibition of Ca2+ release mediated by the α-adrenoceptors, but not by caffeine.
収録刊行物
-
- Jpn.J.Pharmacol.
-
Jpn.J.Pharmacol. 76 (1), 57-63, 1998
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204285262208
-
- NII論文ID
- 10008191124
-
- NII書誌ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK1cXmsFWjsQ%3D%3D
-
- ISSN
- 13473506
- 00215198
-
- NDL書誌ID
- 4395858
-
- PubMed
- 9517405
-
- Web Site
- https://ndlsearch.ndl.go.jp/books/R000000004-I4395858
- https://api.elsevier.com/content/article/PII:S0021519819312478?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S0021519819312478?httpAccept=text/plain
- https://www.jstage.jst.go.jp/article/jjp/76/1/76_1_57/_pdf
- https://search.jamas.or.jp/link/ui/1998107877
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可